These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 7952424
1. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics. Pedersen OD, Gram J, Bagger H, Keller N, Jespersen J. Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424 [Abstract] [Full Text] [Related]
2. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Pedersen OD, Gram J, Jeunemaitre X, Billaud E, Jespersen J. Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181 [Abstract] [Full Text] [Related]
4. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S. Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [Abstract] [Full Text] [Related]
6. Sex differences in the determinants of fibrinolytic activity. MacCallum PK, Cooper JA, Howarth DJ, Meade TW, Miller GJ. Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046 [Abstract] [Full Text] [Related]
7. Alterations in the fibrinolytic system components during acute myocardial infarction. Ioannidou-Papayannaki E, Lefkos N, Boudonas G, Efthimiadis A, Psirropoulos D, Vogas V, Papadopoulos I, Klonizakis I. Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123 [Abstract] [Full Text] [Related]
8. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. Wright RA, Flapan AD, Alberti KG, Ludlam CA, Fox KA. J Am Coll Cardiol; 1994 Jul; 24(1):67-73. PubMed ID: 8006284 [Abstract] [Full Text] [Related]
9. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids. Petersen KR, Kjems LL, Skouby SO, Andersen LF, Jespersen J. Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017 [Abstract] [Full Text] [Related]
10. The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients. Melidonis A, Stefanidis A, Tournis S, Manoussakis S, Handanis S, Zairis M, Dadiotis L, Foussas S. Clin Cardiol; 2000 Mar; 23(3):160-4. PubMed ID: 10761802 [Abstract] [Full Text] [Related]
11. Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemia. Grzywacz A, Elikowski W, Psuja P, Zozulińska M, Zawilska K. Blood Coagul Fibrinolysis; 1998 Apr; 9(3):245-9. PubMed ID: 9663707 [Abstract] [Full Text] [Related]
12. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC. Thromb Res; 2008 Apr; 121(5):675-80. PubMed ID: 17870147 [Abstract] [Full Text] [Related]
13. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C. Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [Abstract] [Full Text] [Related]
14. Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction. Chandler WL, Stratton JR. Am J Clin Pathol; 1994 Aug; 102(2):248-52. PubMed ID: 8042597 [Abstract] [Full Text] [Related]
15. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states. Niwano H, Takahashi H, Tatewaki W, Wada K, Seki Y, Shibata A. Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814 [Abstract] [Full Text] [Related]
16. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB. Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716 [Abstract] [Full Text] [Related]
17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A, Ruusuvaara L. Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043 [Abstract] [Full Text] [Related]
18. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction. Ganti AK, Potti A, Yegnanarayan R. Pathophysiol Haemost Thromb; 2002 Dec 22; 32(2):80-4. PubMed ID: 12214153 [Abstract] [Full Text] [Related]
19. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction. Goto S, Kawai Y, Handa S, Abe S, Takahashi E, Watanabe K, Hori S, Ikeda Y. Cardiology; 1993 Dec 22; 82(4):280-5. PubMed ID: 8402755 [Abstract] [Full Text] [Related]
20. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies. van de Kar NC, van Hinsbergh VW, Brommer EJ, Monnens LA. Pediatr Res; 1994 Aug 22; 36(2):257-64. PubMed ID: 7970942 [Abstract] [Full Text] [Related] Page: [Next] [New Search]